MedTrace Logo

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

NCT01387724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in blood and tissue samples from patients with newly diagnosed neuroblastoma.

Conditions

Interventions

GENETIC

RNA analysis

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

GENETIC

proteomic profiling

GENETIC

western blotting

OTHER

enzyme-linked immunosorbent assay

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

liquid chromatography

OTHER

mass spectrometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Joanna Kitlinska, PhD · Lombardi Comprehensive Cancer Center

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387724 on ClinicalTrials.gov